Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - VistaGen Therapeutics, Inc. | vtgn10k_mar312020.htm |
| EX-32 - CERTIFICATION - VistaGen Therapeutics, Inc. | ex-32.htm |
| EX-31.2 - CERTIFICATION - VistaGen Therapeutics, Inc. | ex-312.htm |
| EX-31.1 - CERTIFICATION - VistaGen Therapeutics, Inc. | ex-311.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We hereby consent to the incorporation by reference in the
Registration Statements on Form S-8 (File Nos. 333-234026,
333-223556 and 333-208354), Form S-3 (File Nos. 333-237968, 333-234025 and
333-215671) and Form S-1 (No. 333-237514) of VistaGen Therapeutics,
Inc. of our report dated June 29, 2020 (which report expresses an
unqualified opinion and includes an explanatory paragraph
expressing substantial doubt about the Company’s ability to
continue as a going concern),
relating to the consolidated financial statements of VistaGen
Therapeutics, Inc., which appears in this Annual Report on Form
10-K.
/s/ OUM & CO. LLP
San Francisco,
California
June
29, 2020